Literature DB >> 32910302

Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.

Catherine Fressinaud1,2, Olivier Thomas3, Anita Monika Umerska3, Patrick Saulnier3.   

Abstract

Promoting remyelination in multiple sclerosis is important to prevent axon degeneration, given the lack of curative treatment. Although some growth factors improve this repair, unspecific delivery to cells and potential side effects limit their therapeutic use. Thus, NFL-TBS.40-63 peptide (NFL)-known to enter specifically myelinating oligodendrocytes (OL)-was used to vectorize 100 nm diameter lipid nanoparticles (LNC), and the ability of NFL-LNC to specifically target OL from newborn rat brain was assessed in vitro. Specific uptake of DiD-labeled NFL-LNC by OL characterized by CNP and myelin basic protein was observed by confocal microscopy, as well as DiD colocalization with NFL and with Rab5-a marker of early endosomes. Unvectorized LNC did not significantly penetrate OL and there was no uptake of NFL-LNC by astrocytes. Canonical maturation of OL which extended compacted myelin-like membranes was observed by transmission electron microscopy in cells grown up to 9 days with NFL-LNC. Endocytosis of NFL-LNC appeared to depend on several pathways, as demonstrated by inhibitors. In addition, vectorized NFL-LNC adsorbed on neurotrophin-3 (NT-3) potentiated the proremyelinating effects of NT-3 after demyelination by lysophosphatidyl choline, allowing noticeably decreasing NT-3 concentration. Our results if they were confirmed in vivo suggest that NFL-vectorized LNC appear safe and could be considered as putative carriers for specific drug delivery to OL in order to increase remyelination.

Entities:  

Keywords:  Lipid nanoparticles; Lysophosphatidyl choline; Multiple sclerosis; Neurotrophin-3; Oligodendrocyte; Remyelination

Mesh:

Substances:

Year:  2020        PMID: 32910302     DOI: 10.1007/s11064-020-03122-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  56 in total

Review 1.  Oligodendrocyte Development and Plasticity.

Authors:  Dwight E Bergles; William D Richardson
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

2.  Design and optimization of PLGA microparticles for controlled and local delivery of Neuregulin-1 in traumatic spinal cord injury.

Authors:  Kallivalappil T Santhosh; Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Control Release       Date:  2017-06-28       Impact factor: 9.776

Review 3.  The role of growth factors as a therapeutic approach to demyelinating disease.

Authors:  Yangyang Huang; Cheryl F Dreyfus
Journal:  Exp Neurol       Date:  2016-03-22       Impact factor: 5.330

Review 4.  Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?

Authors:  Scott A Myers; Andrew N Bankston; Darlene A Burke; Sujata Saraswat Ohri; Scott R Whittemore
Journal:  Exp Neurol       Date:  2016-04-13       Impact factor: 5.330

5.  Neurotrophin-3 specifically increases mature oligodendrocyte population and enhances remyelination after chemical demyelination of adult rat CNS.

Authors:  Isabelle Jean; Céline Lavialle; Annick Barthelaix-Pouplard; Catherine Fressinaud
Journal:  Brain Res       Date:  2003-05-16       Impact factor: 3.252

6.  Axonal lesions and PDGF-enhanced remyelination in the rat corpus callosum after lysolecithin demyelination.

Authors:  Isabelle Jean; Chantal Allamargot; Annick Barthelaix-Pouplard; Catherine Fressinaud
Journal:  Neuroreport       Date:  2002-04-16       Impact factor: 1.837

7.  Repeated injuries dramatically affect cells of the oligodendrocyte lineage: effects of PDGF and NT-3 in vitro.

Authors:  Catherine Fressinaud
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

Review 8.  Glial progenitor cell-based treatment and modeling of neurological disease.

Authors:  Steven A Goldman; Maiken Nedergaard; Martha S Windrem
Journal:  Science       Date:  2012-10-26       Impact factor: 47.728

9.  Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF).

Authors:  Sonja Rittchen; Amanda Boyd; Alasdair Burns; Jason Park; Tarek M Fahmy; Su Metcalfe; Anna Williams
Journal:  Biomaterials       Date:  2015-04-15       Impact factor: 12.479

Review 10.  Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis.

Authors:  Nicola De Stefano; Diego G Silva; Michael H Barnett
Journal:  CNS Drugs       Date:  2017-04       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.